On Tuesday, September 3, Antonio Giordano, the founder and president of the Sbarro Institute for Cancer Research and Molecular Medicine (SHRO) at Temple University, hosted a special tour of the institute’s lab facilities in honor of State Senator Ryan Aument. Aument has been a staunch supporter of SHRO and its research efforts since taking office in 2014, recognizing the importance of Temple’s groundbreaking work in the region and globally.

During the event, Aument was presented with the prestigious Scientific Education Award by Giordano. The award ceremony included a personalized tour of SHRO’s facilities, where Temple researchers are at the forefront of biomedical research, developing innovative healthcare solutions. Aument expressed his gratitude for the recognition, stating, "It’s a privilege to be here on campus, and to have this research facility and partnership between the commonwealth and Temple University is really important." He emphasized Temple’s role in driving economic opportunity through quality research and improving the quality of life for people both in Pennsylvania and worldwide.

Giordano took the opportunity to highlight the significant contributions that Aument has made to Temple’s success, particularly through his efforts to secure a $1 million donation from the commonwealth of Pennsylvania. This funding has played a key role in expanding medical school programs and supporting the recruitment of top-tier researchers to SHRO. "The generous donation to Temple’s medical school came thanks to Sen. Aument," said Giordano. "It allowed us to open new programs and bring in several outstanding investigators for our research."

Temple University’s President Richard M. Englert, who attended the ceremony, expressed his appreciation for Aument’s long-standing support. He spoke of the nearly 60-year partnership between the university and the state, which provides Temple with $158.2 million annually to reduce tuition for Pennsylvania residents. "We are so grateful for the regular funding from the commonwealth, and Sen. Aument has consistently stepped forward as a leader in these initiatives," said Englert.

Provost Gregory N. Mandel also highlighted the importance of this interdisciplinary collaboration, emphasizing its role in preparing the next generation of doctors and researchers. He pointed out that the development of SHRO, driven by both Aument’s support and Giordano’s vision, has had a tangible impact on improving healthcare. "Sen. Aument’s support and Dr. Giordano’s vision have proven to have a real impact on people’s lives," Mandel said, echoing the sentiment that their combined efforts have helped position Temple as a leader in cancer and biomedical research.

Giordano’s work, particularly his discoveries around cell cycle regulation and cancer treatment, was also celebrated during the event. His research has led to the development of small-molecule drugs now widely used in the treatment of various cancers, including breast and lung cancer. His commitment to advancing genetic research continues to drive SHRO’s mission to cure and diagnose cancer, cardiovascular diseases, diabetes, and other chronic illnesses, while also training the next generation of medical professionals.

This event underscored the powerful synergy between state support, academic research, and healthcare innovation, reinforcing the importance of continued collaboration to tackle some of the world’s most pressing health challenges.

For more articles visit here:

Health, interview between oncologist Giordano and Emirati minister Al Hamed

Understanding Cancer Patients with Malnutrition and Metabolic Dysfunction